<DOC>
	<DOCNO>NCT01339182</DOCNO>
	<brief_summary>This study aim assess safety , tolerability , pharmacokinetics , pharmacodynamics single-dose Pegylated-Somatropin healthy male volunteer , collect scientific data design conduct subsequent study .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Pharmacodynamics Study Pegylated-Somatropin Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male subject Age ( yr ) 18 45 Body mass index ( BMI ) 20 28 sign inform consent Known hypersensitivity somatropin component study drug Organic lesion heart , liver , kidney major organ History diabetes mellitus , cancer , autoimmune disease , genetic disease , mental disease Alcoholic , smoker drug abuser Blood donation , massive blood loss due injury surgery within 3 month Other condition opinion investigator preclude enrollment study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>somatropin</keyword>
	<keyword>PK</keyword>
	<keyword>PD</keyword>
	<keyword>male</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>pharmacodynamics</keyword>
	<keyword>safety</keyword>
</DOC>